Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Effects of Sulphate-Sulphide Mineral Water „Mlječanica“ in Patients with Hypertension

Tatjana Erceg-Rukavina, Mihajlo Stefanovski.




Abstract

Introduction: Arterial hypertension is the main independent risk factor for cardiovascular (CV) disease and death. It affects development and course of cerebrovascular insult (CVI) and chronic kidney disease (CKD). Balneotherapy with sulphide baths was administered to patients having stage I hypertension (BP values 140-159/90-99), with no arrhythmia or pronounced coronary disease. Baths also had advantage in patients having hypertension joined with obesity, diabetes, microangiopathy, and atherosclerosis of peripheral arteries. Goal: Determine the effects of sulphate-sulphide mineral baths on stage I hypertension after 10 days therapy. Materials and methods: Patients having stage I hypertension were sent to “Mlječanica” Institute for rehabilitation. All subjects were treated with kinesitherapy and electrotherapy, while experimental group (n=30) was also treated with 20 minute baths, daily, for period of 10 days. Results: In experimental group BP level lowered in average 10 mmHg after 10-day therapy, and change was evident even after only 5 days. Conclusion: Sulphate-sulphide mineral water “Mlječanica” caused significant (p

Key words: sulphate-sulphide mineral water, arterial hypertension.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.